Argyrophilic staining of nucleolar organizer region count and morphometry in benign and malignant melanocytic lesions

American Journal of Dermatopathology

Volumn 25, Issue 3, 2003, Pages 190-197

  Li, Ling Xi L ^a,b   Crotty, Kerry A ^a   Palmer, Allan A ^a   Kril, Jillian J ^b,c   Scolyer, Richard A ^a   Thompson, John F ^a,b   McCarthy, Stanley W ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

Argyrophilic staining of nucleolar organizer region (AgNOR); Count; Melanocytic lesion; Melanoma; Morphometry; Nevi; Spitz nevi

Indexed keywords

ADOLESCENT; ADULT; ARGENTAFFIN CELL; ARTICLE; CHILD; CHROMOSOME NOR; DIAGNOSTIC ACCURACY; DYSPLASTIC NEVUS; FEMALE; HISTOLOGY; HUMAN; IMAGE ANALYSIS; JUVENILE MELANOMA; MAJOR CLINICAL STUDY; MALE; MELANOCYTE; MELANOCYTIC NEVUS; MELANOMA; MORPHOMETRICS; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; VIDEORECORDING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL NUCLEUS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEVUS; NUCLEOLUS ORGANIZER REGION; SILVER STAINING; SKIN NEOPLASMS;

EID: 0037794318     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-200306000-00002     Document Type: Article

References (49)

1. Crocker J. Nucleolar organizer regions, fibrillar centres and lymphomas. In: Proliferation in lymphomas. 1st ed. Oxford: Blackwell Scientific, 1993:145-84.
2. Derenzini M. The AgNORs. Micron 2000;31:117-20.
3. Ploton D, Menager M, Jeannesson P, et al. Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J 1986; 18:5-14.
4. Miller DA, Dev VG, Tantravahi R, et al. Suppression of human nucleolus organizer activity in mouse-human somatic hybrid cells. Exp Cell Res 1976;101:235-43.
5. Raman R, Sperling K. Patterns of silver staining on NORs of prematurely condense muntjac chromosomes following RNA inhibition. Exp Cell Res 1981;135:373-8.
6. Walker RA. The histopathological evaluation of nucleolar organizer region proteins [commentary]. Histopathology 1988;12:221-3.
7. Pich A, Chiusa L, Margaria E. Prognostic relevance of AgNORs in tumor pathology. Micron 2000;31:133-41.
8. Canet V, Montmasson MP, Usson Y, et al. Correlation between silver-stained nucleolar organizer region area and cell cycle time. Cytometry 2001;43:110-6.
9. Morgan DW, Crocker J, Watts A, et al. Salivary gland tumours studied by means of the AgNOR technique. Histopathology 1988; 13:553-9.
10. Sinn HP, Lehnert T, Kandetzki C, et al. Nucleolar organizer regions in myogenic stromal tumours of stomach. Virchows Arch A Pathol Anat 1989;415:317-21.
11. Egan M, Freeth M, Crocker J. Intraepithelial neoplasia, human papilloma virus infection and argyrophilic nucleoprotein in cervical epithelium. Histopathology 1988;13:561-7.
12. Cullimore JE, Rollason TP, Marshall T. Nucleolar organiser regions in adenocarcinoma in situ of the endocervix. J Clin Pathol 1989;42:1276-80.
13. Marbaix E, Dewandeleer S, Habba C, et al. Nucleolar organizer regions in the normal and carcinomatous epithelium of the uterine cervix a morphometric study. Int J Gynecol Pathol 1989;8:237-45.
14. Rüschoff J, Plate K, Bittinger A, et al. Nucleolar organizer regions (NORs): basic concepts and practical application in tumor pathology. Pathol Res Pract 1989;185:878-85.
15. Crocker J, Egan MJ. Correlation between NOR sizes and numbers in non-Hodgkin's lymphomas. J Pathol 1988;156:233-9.
16. Munakata S, Hendricks JB. Morphometric analysis of AgNORs in imprints and sections from non-Hodgkin's lymphomas. An approach to standardization. Anal Quant Cytol Histol 1993;15:329-34.
17. Rüschoff J, Bittinger A, Neumann K, et al. Prognostic significance of nucleolar organizing regions (NORs) in carcinomas of the sigmoid colon and rectum. Pathol Res Pract 1990;186:85-91.
18. Weeks SC, Beroukas D, Jarvis LR, et al. Video image analysis of AgNOR distribution in the normal and adenomatous colorectum. J Pathol 1992;166:139-45.
19. Charpin C, Bonnier P, Piana L, et al. Correlation of nucleolar organizer regions and nuclear morphometry assessed by automatic image analysis in breast cancer with aneuploidy, Ki67 immunostaining, histopathologic grade and lymph node involvement. Pathol Res Pract 1992;188:1009-17.
20. Crocker J, Skilbeck N. Nucleolar organiser region associated proteins in cutaneous melanotic lesions: a quantitative study. J Clin Pathol 1987;40:885-9.
21. Fallowfield ME, Cook MG. Nucleolar organiser regions in melanocytic dysplasia. J Pathol 1988;154:45A.
22. Mackie RM, White SI, Seywright MM, et al. An assessment of the value of AgNOR staining in the identification of dysplastic and other borderline melanocytic naevi. Br J Dermatol 1989;120:511-6.
23. Leong AS-Y, Gilham P. Silver staining of nucleolar organizer regions in malignant melanoma and melanotic nevi. Hum Pathol 1989;20:257-62.
24. Pich A, Aloi F, Margaria E, et al. Argyrophilic nucleolar organizer region counts in malignant melanoma associated with intradermal nevus. Dermatologica 1991;183:246-50.
25. Koren R, Rath-Wolfson L, Appel I, et al. Nucleolar organizer regions in conjunctival nevi and melanomata. Oncol Rep 1998;5:1079-81.
26. Barzilai A, Goldberg I, Yulash M, et al. Silver-stained nucleolar organizer regions (AgNORS) as a prognostic value in malignant melanoma. Am J Dermatopathol 1998;20:473-7.
27. Howat AJ, Giri DD, Cotton DWK, et al. Nucleolar organizer regions in Spitz nevi and malignant melanomas. Cancer 1989;63:474-8.
28. Nagatani T, Iemoto G, Miyakawa K, et al. AgNOR (nucleolar organizer regions) staining in malignant melanoma. J Dermatol 1991;18:731-5.
29. Gonzalez AP, Kumar D, Sánchez R. AgNORs area measurement differentiate benign and malignant melanocytic lesions more accurately than simple counting. Am J Dermatopathol 1994;16:372-6.
30. McLean IW, Sibug ME, Becker RL, et al. Uveal melanoma. The importance of large nucleoli in predicting patient outcome - an automated image analysis study. Cancer 1997;79:982-8.
31. Elder DE, Murphy GF. Atlas of tumor pathology: melanocytic tumors of the skin. Washington, DC: Armed Forces Institute of Pathology, 1991.
32. Crocker J, Boldy DAR, Egan MJ. How should we count AgNORs proposals for a standardized approach. J Pathol 1989;158:185-8.
33. Li L-XL, Crotty KA, Palmer AA, et al. Melanin bleaching in argyrophilic staining of nucleolar organizer regions (AgNORs) in pigmented lesions: a morphometric evaluation. Anal Quant Cytol Histol 2002;24:166-72.
34. Coghill G, Grant A, Orrell JM, et al. Improved silver staining of nucleolar organiser regions in paraffin sections using an inverted incubation technique. J Clin Pathol 1990;43:1029-31.
35. Delahunt B, Avallone FA, Ribas JL, et al. Gold toning improves the visualization of nucleolar organizer regions in paraffin embedded tissue. Biotech Histochem 1991;66:316-20.
36. Norusis MJ. SPSS introductory statistics student guide. Chicago: SPSS, 1990:201-3.
37. Schmoeckel C. How consistent are dermatopathologists in reading early malignant melanomas and lesions "precursor" to them? Am J Dermatopathol 1984;6(Suppl):13-24.
38. Farmer ER, Gonin R, Hanna MP. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol 1996;27:528-31.
39. Crocker J, Nar P. Nucleolar organizer regions in lymphomas. J Pathol 1987;151:111-8.
40. Öfner D, Tötsch M, Sandbichler P, et al. Silver stained nucleolar organizer region proteins (Ag-NORs) as a predictor of prognosis in colonic cancer. J Pathol 1990;162:43-9.
41. Egan M, Raafat F, Crocker J, et al. Comparative study of the degree of differentiation of neuroblastoma and mean numbers of nucleolar organiser regions. J Clin Pathol 1988;527-31.
42. Trerè D, Farabegoli F, Cancellieri A, et al. AgNOR area in interphase nuclei of human tumors correlates with the proliferative activity evaluated by bromodeoxyuridine labelling and Ki-67 immunostaining. J Pathol 1991;165:53-9.
43. Fallowfield ME, Dodson AR, Cook MG. Nucleolar organizer regions in melanocytic dysplasia and melanoma. Histopathology 1988;13:95-9.
44. Friedman RJ, Grin CM, Heilman E, et al. Distinguishing benign and malignant melanocytic lesions with the AgNOR method. Dermatol Clin 1991;9:689-93.
45. Staibano S, Orabona P, Mezza E, et al. Morphometric analysis of AgNORs in uveal malignant melanoma. Anal Quant Cytol Histol 1998;20:483-92.
46. Howat AJ, Giri DD, Wright AL, et al. Silver-stained nucleoli and nucleolar organizer region counts are of no prognostic value in thick cutaneous malignant melanoma. J Pathol 1988;156:227-32.
47. Giri DD, Nottingham JF, Lawry J, et al. Silver-binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions: correlations with ploidy and growth phase by DNA flow cytometry. J Pathol 1989;157:307-13.
48. Trere D. AgNOR staining and quantification. Micron 2000;31:127-31.
49. Darnton SJ, Gray MR, Crocker J. Another cautionary note on the use of PCNA and AgNORs as markers of proliferation [letter]. J Pathol 1992;168:87.